AXIM Launches New Eye Care Website; Establishes Platform for Commercialization
June 02, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
Insights on the Eye Drops Industry in Saudi Arabia to 2027 - by Type, Drug Class, Disease Indication, Distribution Channel, End-user and Region
June 02, 2022 04:33 ET
|
Research and Markets
Dublin, June 02, 2022 (GLOBE NEWSWIRE) -- The "Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF,...
Digital Vision Screening Platform Aims to Decrease Vision Loss Rates for Patients With Eye Disorders
May 24, 2022 11:00 ET
|
Retina Technologies, Inc
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Retina Technologies, Inc. ("RetTech") is advancing the development of OcuVue™, an affordable, digital vision screening platform with integrated...
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
May 24, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
AXIM Biotechnologies Develops Novel Tear Sample Collector System, Files Patent Application
May 10, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye disease...
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
April 27, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
Global $22+ Billion Ocular Implants (Glaucoma Implants, Intraocular Lens) Markets to 2030: Increasing Focus on the Development of Technologically Advanced Products is Expected to Drive the Market
March 18, 2022 05:03 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Ocular Implants Market Size, Share & Trends Analysis Report by Product (Glaucoma Implants, Intraocular Lens), by Application (Glaucoma Surgery,...
$616.31Mn by 2028, Optical Coherence Tomography Angiography Equipment Market Size, 6.8% CAGR Lead by Tabletop Type - Exclusive Research Report by The Insight Partners
March 17, 2022 07:00 ET
|
The Insight Partners
New York, March 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Optical Coherence Tomography Angiography Equipment Market Forecast to 2028 - COVID-19 Impact and...
Worldwide Ophthalmology Industry to 2027 - Surge in Research and Development to Provide New Treatment Presents Opportunities
January 18, 2022 05:08 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been...
Physician Growth Partners Advises Associates in Ophthalmology in a Partnership With Spectrum Vision Partners
January 17, 2022 09:00 ET
|
Physician Growth Partners
CHICAGO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners ("PGP") is proud to have served as the exclusive adviser to Associates in Ophthalmology ("AIO" or "the Practice") in a...